How Jim Simons Built the World’s Most Lucrative Black Box (Bloomberg) Anyone looking to learn how a quant fund conquered the financial world should...
Keep Reading →
November 1 - Hedge Funds, Insider Trading - Comments
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week. Here is why the...
Keep Reading →
September 24 - Hedge Funds, Insider Trading, News - Comments
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value...
Keep Reading →
May 1 - Hedge Funds, News - Comments
Genomic Health Inc (NASDAQ:GHDX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors...
Keep Reading →
March 15 - Hedge Funds - Comments
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros...
Keep Reading →
March 12 - Hedge Funds - Comments
Seattle Genetics Inc (NASDAQ:SGEN): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors...
Keep Reading →
February 7 - Hedge Funds - Comments
Beigene Ltd (ADR) (BGNE): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors’...
Keep Reading →
January 26 - Hedge Funds - Comments
Mirati Therapeutics Inc. (NASDAQ:MRTX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros....
Keep Reading →
November 21 - Hedge Funds - Comments
Erytech Pharma SA (ADR) (NASDAQ:ERYP): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors...
Keep Reading →
November 20 - Hedge Funds - Comments
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros...
Keep Reading →
October 31 - Hedge Funds - Comments
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros...
Keep Reading →
October 17 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION...
Keep Reading →
August 15 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
August 3 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
June 2 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Keep Reading →
May 18 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
May 18 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing SCHEDULE 13G SECURITIES AND EXCHANGE...
Keep Reading →
April 15 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
March 30 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
March 30 - Hedge Funds - Comments
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker...
Keep Reading →
November 24 - Hedge Fund Analysis, Hedge Funds, News - Comments
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
Keep Reading →
November 14 - Hedge Funds, News - Comments
A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting...
Keep Reading →
September 22 - Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors reported raising its stake in Seattle Genetics Inc (NASDAQ:SGEN) to 44.35 million common shares,...
Keep Reading →
September 16 - Hedge Funds, News - Comments
Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst...
Keep Reading →
August 17 - Hedge Funds, News - Comments
Julian Baker and Felix Baker, the managers of Baker Bros. Advisors, have taken advantage of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) recently announced...
Keep Reading →
August 15 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things...
Keep Reading →
March 8 - Hedge Funds, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
Keep Reading →
February 25 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the...
Keep Reading →
February 24 - Hedge Funds, News - Comments
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should...
Keep Reading →
February 24 - Hedge Funds, News - Comments
As a new 13D filing with the SEC has revealed, Julian and Felix Bakers‘ Baker Bros. Advisors amassed a substantial position in the recently public...
Keep Reading →
February 22 - Hedge Funds, News - Comments
According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers‘ Baker Bros. Advisors are bullish on Anacor Pharmaceuticals...
Keep Reading →
February 10 - Hedge Funds, News - Comments
According to statistics from Hedge Fund Research, the average hedge fund lost 2.76% in January, compared to a decline of approximately 5% for the S&...
Keep Reading →
February 10 - Hedge Funds, News - Comments
Most equity investments made by hedge funds are based on strong reasoning and comprehensive analysis, so these investment vehicles do not make blind...
Keep Reading →
January 29 - Hedge Funds, News - Comments
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking...
Keep Reading →
January 28 - Hedge Funds, News - Comments
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990. Nonetheless, approximately...
Keep Reading →
January 22 - Commodities, Hedge Funds, News - Comments
At Insider Monkey, we closely monitor the moves made by activist investors. Their targets are often undervalued stocks with firm foundations that for...
Keep Reading →
January 20 - Hedge Funds - Comments
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared...
Keep Reading →
December 28 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded...
Keep Reading →
November 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In...
Keep Reading →
September 16 - Hedge Funds, News - Comments
At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock....
Keep Reading →
August 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
Was Baker Bros. Advisors‘ investment in XOMA Corp (NASDAQ:XOMA) a mistake? According to a recent filing with the Securities and Exchange Commission...
Keep Reading →
July 26 - Hedge Funds, News - Comments
Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock...
Keep Reading →
July 13 - Hedge Funds, News - Comments
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
Keep Reading →
July 10 - Hedge Funds, News - Comments
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc...
Keep Reading →
March 5 - Hedge Funds, News - Comments
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics,...
Keep Reading →
February 4 - Hedge Funds, News - Comments
Another one of the funds we track here at Insider Monkey has made a big move into Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), as it was revealed...
Keep Reading →
January 26 - Hedge Funds, News - Comments
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position...
Keep Reading →
January 21 - Hedge Funds, News - Comments
As a new filing with the Securities and Exchange Commission showed, Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has been added to the equity portfolio...
Keep Reading →
January 13 - Hedge Funds, News - Comments
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1...
Keep Reading →
December 29 - Hedge Funds, News - Comments
